stockportfolio.pro
ADMA Biologics, Inc. Gross Profit 2011–2025
ADMA Biologics, Inc. (ADMA) annual gross profit by fiscal year, computed from SEC filings. Compound growth +56.5%/yr over 14 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $292.76M | 57.4% | +33.3% |
| FY 2024 | $219.55M | 51.5% | +146.8% |
| FY 2023 | $88.94M | 34.4% | +152.2% |
| FY 2022 | $35.27M | 22.9% | +2906.4% |
| FY 2021 | $1.17M | 1.4% | +106.2% |
| FY 2020 | $-19.07M | -45.2% | -87.8% |
| FY 2019 | $-10.16M | -34.6% | +59.7% |
| FY 2018 | $-25.21M | -148.4% | -293.7% |
| FY 2017 | $-6.40M | -28.1% | -248.9% |
| FY 2016 | $4.30M | 40.3% | +50.0% |
| FY 2015 | $2.87M | 39.9% | +31.9% |
| FY 2014 | $2.17M | 36.7% | +108.1% |
| FY 2013 | $1.04M | 34.0% | +132.5% |
| FY 2012 | $449,062 | 40.2% | -18.9% |
| FY 2011 | $553,472 | 72.7% | — |
Source: ADMA Biologics, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for ADMA Biologics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeADMA Biologics, Inc. — frequently asked questions
What is ADMA Biologics, Inc.'s gross profit?
ADMA Biologics, Inc. (ADMA) reported gross profit of $292.76M for fiscal year 2025, per its SEC filings.
How has ADMA Biologics, Inc.'s gross profit changed over time?
Between fiscal 2011 and 2025, ADMA's gross profit grew at roughly 56.5% per year (compound annual rate), from $553,472 to $292.76M.
Where does this data come from?
Figures are computed from ADMA Biologics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.